Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.10.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
Current Assets:    
Cash and cash equivalents $ 1,232 $ 576
Prepaid expenses 15 0
Total Current Assets 1,247 576
Intangible assets 25,263 253,777
Deposits 21 9
Fixed assets, net 5 6
Total Other Assets 25,289 253,792
TOTAL ASSETS 26,536 254,368
Current Liabilities:    
Accounts payable 2,251 2,546
Accrued expenses 344 102
Line of credit 31 31
Convertible debentures, net of discount of $488 10,597 0
Total Current Liabilities 13,223 2,679
Total liabilities 13,223 2,679
Stockholders' Deficit:    
Common stock - $0.001 par value; 750,000,000 shares authorized; and 50,227,978 and 50,117,977 shares issued and outstanding at September 30, 2018 and December 31, 2017, respectively 50 50
Additional paid-in capital 537,883 521,305
Accumulated deficit (524,453) (269,499)
Noncontrolling interest (169) (169)
Total Stockholders' Deficit 13,313 251,689
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT 26,536 254,368
Series C    
Stockholders' Deficit:    
Convertible preferred stock - $0.001 par value; 15,000,000 shares authorized: 1 1
Series J    
Stockholders' Deficit:    
Convertible preferred stock - $0.001 par value; 15,000,000 shares authorized: $ 1 $ 1